To hear about similar clinical trials, please enter your email below
Trial Title:
Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV
NCT ID:
NCT05496556
Condition:
Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations
Conditions: Official terms:
Carcinoma
Malnutrition
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Other
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Test Leeds Food Preference Questionnaire (LFQP-France)
Description:
The version of this questionnaire has been adapted to French eating habits. and based on
the presentation of food photos, each representing one of the four categories below :
salty-high in fat / salty-low fat / sugary-high fat / sweet-low fat The answers given to
the LFQP predict a more or less caloric food intake. This tool makes it possible to
objectify changes in eating behavior according to the nutritional status and protein
status of patients.
The implied wanting score for salty-high-fat, salty-low-fat, sweet-high-fat, and
sweet-low-fat foods is calculated based on the frequency and speed of choice for one food
type out of 150 combinations.
For each of the food modalities, the software will return a score with its standard
deviation. The modality preferred by the patient is the one with the highest score
Arm group label:
All patients included in the study
Summary:
The study will be offered to patients with non-small cell lung carcinoma diagnosed at
stage IV and receiving first-line treatment.
The patient will benefit from a complete assessment at inclusion (clinical exam, imagery,
biological exam, dietary consultation, test LFQP.
At the end of this 1st evaluation, patients in whom the diagnosis of undernutrition is
made will benefit from dietary management with personalized advice that will take into
account the symptoms of cancer, the possible side effects of treatments as well as the
social environment.
Every two cures, i.e. every 4 to 6 weeks, these examens will be performed until the
occurrence of an event (progression of the disease according to the RECIST criteria,
death or change of therapeutic line). At the end of these assessments, patients will
benefit from dietary management with a readjustment of personalized advice that will take
into account the difficulties highlighted during the assessment.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Diagnosis of stage IV non-small cell lung carcinoma with indication for first-line
systemic treatment (chemotherapy, immunotherapy or specific treatment, in particular
tyrosine kinase inhibitors) according to current French recommendations.
- Age over 18 and under 70
- Patient speaking and reading French fluently
- Affiliation to a social security scheme
- Patient able and willing to follow all study procedures in accordance with the
protocol
- Patient having understood, signed and dated the consent form
Exclusion Criteria:
- Patient requiring hospitalization for more than 48 hours for the administration of
the first course of treatment
- Patient benefiting from antibiotic therapy for the treatment of an acute infection
- Psychiatric, cognitive or neurological disorders making it impossible to assess food
preferences and/or any impossibility to undergo medical monitoring for the trial for
geographical, social or psychological reasons.
- Daily alcohol consumption
- Chest radiotherapy treatment
- Pregnant woman, likely to be, or breastfeeding
- Persons deprived of liberty or under guardianship
Gender:
All
Minimum age:
18 Years
Maximum age:
70 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Centre Georges-François Leclerc
Address:
City:
Dijon
Zip:
21000
Country:
France
Status:
Recruiting
Contact:
Last name:
MARJOLAINE GEORGES, Dr
Phone:
03 80 29 37 72
Phone ext:
+33
Email:
marjolaine.georges@chu-dijon.fr
Contact backup:
Last name:
Sophie PARNALLAND
Phone:
03 45 34 80 77
Phone ext:
+33
Email:
sparnalland@cgfl.fr
Start date:
November 1, 2023
Completion date:
November 1, 2025
Lead sponsor:
Agency:
Centre Georges Francois Leclerc
Agency class:
Other
Source:
Centre Georges Francois Leclerc
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05496556